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Cancer is a leading cause of mortality and one of the most feared diseases in modern society. A combination of early 
detection, accurate diagnosis and effective treatment provides the best defence against cancer morbidity; therefore, 
promoting cancer awareness and encouraging cancer screening is a priority in any comprehensive cancer control 
policy. Colorectal cancer is the third most common form of cancer in the UK and in an effort to reduce the high 
incidence, prevalence, morbidity and mortality rates, the National Health Service (NHS) has introduced the NHS 
Bowel Cancer Screening Programme (NHS BCSP). For the NHS BCSP to succeed in its goal of reducing the 
incidence and prevalence rates for colorectal cancer, individuals need to be persuaded to complete the test. Since it 
was first introduced in 2007, however, participation rates have been low. In an effort to understand why participation 
rates remain low, this article reports on the findings of a series of focus groups conducted in the East Midlands of 
England. These focus groups were designed to explore the factors that influence an individual’s decision to 
participate in cancer screening. The findings revealed eight factors that affected participation in the NHS BCSP: (i) 
the association of screening with entry into old age; (ii) prior experience with health systems; (iii) the support of a 
significant other; 
(iv) individual perceptions of risk (and benefit); (v) fear of becoming a cancer patient after the screening test; 
(vi) lack of disease symptoms; (vii) embarrassment associated with completing the test and (viii) messages 
that adopt 
a paternalistic ethos. Overall, our results suggest that more people may participate in the screening 
programme if it was more sensitive to these psychosocial and contextual factors that shape an individual’s 
decision to be tested. European Journal of Cancer Prevention 00:000–000 Qc   2014 Wolters Kluwer Health | 




Colorectal cancer (CRC) is a leading cause of morbidity and mortality in the western world 
(Hewitson et al., 2007). In 2010, 40 695 people were diagnosed,  and  B16 000 people died from 
CRC in the UK (Cancer Research UK, 2010). CRC is the third most common type of cancer in 
men and women and the second most common cause of cancer mortality in the UK, and it 
accounts for around 10% of all cancer deaths (Cancer Research UK, 2010). Late diagnosis is 
one of the key factors contributing to CRC mortality, and in an effort to reduce the high incidence, 
prevalence, morbidity and mortality rates, the UK government has implemented the National 
Health Service Bowel Cancer Screening Programme (NHS BCSP). 
The NHS BCSP uses a biannual faecal occult blood test (FOBt) to screen for blood in the stools. Early 
detection through the FOBt has been shown to reduce mortality from CRC by 16% (Hewitson et al., 
2007). In the UK, people aged 60–69 years are sent an invitation letter, information leaflet and test kit 
to their home address. Recipients are encouraged to complete the home-based test and then return 
the samples in the reply-paid envelope. A positive test result (i.e. detection of blood in 
the stools) indicates the need for a follow-up diagnostic examination, usually a colonoscopy. To 
make an informed decision about whether to complete the screening test, individuals are 
informed that the screening test is not a diagnostic test and that the sensitivity and specificity 
of the test is not absolute. This means that some individuals who return a positive FOBt will not 
have cancer, or alternatively, some individuals with early stage CRC will not return a positive 
FOBt. Despite the occasional false- positive or false-negative result, clinical trials have shown 
that the FOBt is the safest and most cost-effective screening test currently available (Flight et 
al., 2008). 
 
Population-wide cancer screening is one of several programmes that contribute to the national 
strategy to improve cancer services and reduce cancer morbidity in the UK (Department of Health, 
2007). Cancer screening  is also emblematic of the ideological shift from the ‘old  public health’ to 
the ‘new public health’ (Tulchinsky and Varavikova, 2010). Whereas the ‘old public health’ was 
concerned with reducing the burden of cancer after diagnosis, the emphasis in the ‘new public health’ 
is on primary prevention, health education and health promotion. In what Armstrong (2012) has 
described as ‘surveillance medicine’, individuals are encouraged to seek health information from 
reliable sources, and on the basis of this information, they are encouraged to make rational and 
informed choices about how to delay, avert or prevent the onset of illness. The role of government 
is limited to a ‘surveillance’ or ‘monitoring’ function, whereby public health officials use 
surveillance techniques such as screening to identify individuals at risk. Such characteristics 
concur with Lupton’s (1995) suggestion that within the new public health regime, there is more 
emphasis on promoting self-efficacy and empower- ing individuals to make informed choices 
about their health, rather than relying on a paternalistic government to manage the nation’s 
health. 
 
Alongside this transition from the ‘old’ to the ‘new’ public health, modern western societies are 
undergoing a demographic transition. This means that whereas one in six people in the UK are currently 
aged 65 years and over, by 2050 one in four people will  be aged 65 years and  over (Cracknell, 2010). 
As CRC is a disease that primarily affects older people, where eight out of every 10 pat ients are over 
60 years of age (West et al., 2007), it is likely that the annual incidence of CRC will increase as the UK 
continues to undergo this demographic transition. For many older people, cancer is the most feared 
disease (Griffiths, 1995) and has been shown to be feared more than having a heart attack, developing  
Alzheimer’s  disease or being a victim of a terrorist attack (Department of Health, 2007). Research has 
shown that this fear of cancer is experienced by individuals with no diagnosis as well as by those who 
have recovered from cancer. Horlick- Jones (2011), for example, describes how ‘fear of cancer 
recurrence’ can have a detrimental effect on the quality    of life and wellbeing of people who are in the 
recovery phase or who have recovered from cancer. It is likely that this ‘fear of cancer’ is a key factor 
when older  people make the decision about whether or not to participate in CRC screening, and it is 
important that such fears are sensitively addressed in the NHS BCSP. 
 
For the NHS BCSP to succeed in its goal of reducing the incidence and prevalence rates for CRC, 
individuals need to be persuaded to complete the test. Since it was first introduced in 2007, 
however, participation rates have been low, especially for men, people from lower socioeconomic 
backgrounds and people from ethnic minority groups (Weller et al., 2007; Szczepura et al., 2008). 
In an effort to explain these differential participation rates, previous studies have shown that a 
range of social and environ- mental factors can influence the decision to participate in CRC 
screening programmes. These include a person’s sex, age, ethnicity, socioeconomic status, level of 
education and health literacy (Keighley et al., 2004; Wackerbarth   et al., 2005; Thompson et al., 
2011). O’Sullivan and Orbell (2004) found that whereas the FOBt was seen as socially acceptable, 
concerns were raised about collecting and storing faecal matter. Similarly, participants in a study 
by Chapple et al. (2008) indicated a reluctance to handle stools and send samples in the post for 
analysis, but suggested that ‘civic responsibility’ was a driver for completing the test. Other 
investigators  have  explored the role of general practitioners (GPs) in an individual’s decision-making 
process, and these studies suggest that uptake would be higher if GP’s were more actively involved in 
promoting the benefits of the BCSP to their patients (Beeker et al., 2000). Damery et al. (2010)  
conclude from their study that ‘the success of population-based screening for CRC will be determined 
to  a large extent by GP attitudes, beliefs and support, particularly with regard to faecal occult blood 
testing’ (West et al., 2007). It is likely that the traditional doctor– patient relationship of trust is still an 
important factor in a person’s decision-making process, and especially for older people who are the 
primary target for the NHS FOBt. We argue that the uptake, and thereby the success, of  the NHS 
BCSP is largely determined by each individual’s response to the programme, and that this response 
is shaped by their knowledge and attitudes of CRC in particular and public health more broadly. In turn, 
an individual’s response to the BCSP is determined by a combination of biographical, psychosocial 
and contextual factors. This study set out to explore these interlocking factors by investigating the 
attitudes of individuals  living in the East Midlands of England towards the NHS BCSP. 
 
Methods 
A focus group methodology was used to identify and understand the factors that encourage or 
discourage individuals from participating in the BCSP. The focus group methodology was chosen 
because we were interested in both individual responses to the questions and interactions that 
take place between individuals, as each member of the group responded to the discussion 
questions and to each other (Kitzinger, 1994). We noted whether people confirmed or modified 
their own response after listening to the views of others. 
Approval from a multicentre NHS research ethics committee was obtained to conduct this study. 
A semistructured interview guide was used during the focus groups, with additional probing 
questions drawn spontaneously from the discussion (see Fig. 1 for the interview schedule). The 
interview guide was developed from a preliminary review of the published literature of previous 
studies that explored the drivers and barriers to participation in cancer screening. A pilot focus 
group was conducted to evaluate the questions and to appraise the suitability  of  conducting  
mixed-sex  groups.  Given the sensitivity of the topic, we initially planned to conduct single sex 
focus groups, but after the pilot focus group, we decided that the mixed sex group did not inhibit 
open discussion, but rather, stimulated an interesting discussion about the gendered differences 






(1) Are you aware of the NHS BCSP? 
 
(2) Have you seen any posters or leaflets raising awareness of the BCSP? 
 
(3) Do you think screening is important? why or why not? 
 
(4) Can you tell us what you know about the disease cancer? 
 
(5) Can you tell us what you know about bowel cancer? 
 
(6) What might be the benefits of the BCSP? 
 
(7) Have you participated in the BCSP? why or why not? 
 
 
(8) Do you have any family or friends that have decided to participate, or not, in the BCSP? have you discussed the reasons why they did or did not participate? 
 
 
(9) Have you undergone screening for any other cancers? 
 
 
(10) What changes could be made to the NHS Bowel cancer screening programme to encourage more people to participate? 
 
Focus group questions. NHS BCSP, National Health Service Bowel Cancer Screening Programme. 
 
 
Including the pilot focus group, we conducted five mixed-sex focus groups. The total number of 
participants was 33 (15 male and 18 female). These were drawn  from three towns within the 
county that were socio- economically representative of the county as a whole. Community-based 
public health staff with links to community groups used purposeful sampling to recruit a balanced 
mix of ages, sex and socioeconomic back- grounds for people who met the eligible criteria for 
participation. Exclusion criteria for the study were people under 60 or over 69 years of age, people 
living outside the county and those who were non-English speaking. As all our participants were 
aged 60 years and over, 85% were retired (94% of women and 73% of men). Previous 
 
occupations, however, included a self-employed window cleaner, shop assistant, secretary, 
government officer and engineer; thus, our sample included a wide range of occupational 
backgrounds. A brief postcode analysis indicated a good distribution across neighbourhood 
deprivation quintiles, with a mean index of multiple deprivation score of 22.06 and a deprivation 
quintile of 3. 
Upon arrival, participants were welcomed by the research team and offered light refreshments. 
Being a sensitive topic, we wanted to ensure that all the participants were comfortable talking as 
a group. As a prelude to the focus group discussion, a short presentation on the epidemiology 
and risk factors for bowel cancer was given to set the context for the study and to initiate thinking 
around  the topic. The  participants  were  then  provided  with a participant information sheet and 
were invited to sign a consent form that provided an assurance that their participation was 
voluntary, that they were not obliged to answer all questions, that they were free to withdraw from 
the study at any stage and that their privacy and confidentiality would be protected throughout 
the transcription, analysis and write up phases of the study. 
The focus groups were constructed specifically for the research, rather than being a pre-existing or 
natural group. With a few exceptions, group members did not know each other before the focus 
group session. We felt this would enable a more open and honest discussion because the 
participants would be less fearful about disclosing  personal or embarrassing information to friends 
or colleagues. For consistency, all the focus groups were facilitated by  the  same  researchers.  All  
participants were aged between  60  and  69 years because  the  FOBt is offered only to this age 
group. Two focus groups were held during the day and three were held in the evening. This was a 
deliberate strategy to make the focus groups accessible to a wider range of people. The duration 
of  each focus group was between 60 and 90 min. Data collection was continued until data 
saturation, that  is,  until we felt that no new ideas were emerging from the discussions. Participants 
were given a £20.00 store voucher at the end as an expression of gratitude for their contribution. 
They were unaware of this at the recruitment stage, thereby ensuring that altruism, rather than 
payment, was the reason for participating. 
After transcription, the transcripts were analysed to identify the factors that influenced the 
decisions to be, or not to be, tested for CRC. In presenting the quotations, we have indicated 
whether it is a male (M) or a female (F) speaking. 
 
Findings 
From the analysis of our qualitative focus group data, we identified eight factors that influence the 
decision to participate in the BCSP. These were a person’s age and wider social attitudes to ageing; 
a person’s previous exposure to healthcare and prior experience with health screening ; the 
influence of significant others; an individual’s perception of risk and their propensity to display an 
optimistic bias; a general fear of cancer and attitude of ‘ignorance is bliss’; lack of disease 
symptoms resulting in an attitude of not needing to be tested; embarrassment  and finally, a 
resistance to paternalistic healthcare. Ultimately, what emerges is a complex interplay between 
individuals and the wider healthcare system as individuals attempt to balance the risks and benefits 
as they decide whether or not to complete the screening test. 
 
Association of screening with entry into ‘old age’ 
The first factor to influence the decision to participate in CRC screening was a person’s age. 
Our participants appeared to associate the screening test with entry into the socially 
constructed category of ‘old age’ and wanted to avoid the stereotypical image that associates 
older age with chronic illness. They resisted the idea that once a person reaches the age of 60 
years, their health declines and they become a perpetual patient, in this case a ‘cancer patient’. 
From the point of view of our participants, these negative images of age and illness were 
amplified when they received a letter from the NHS saying that they were now expected to 
complete a bowel cancer screening test. One of our participants received his letter on his 60th 
birthday and felt this was stepping onto the slippery slope. He exclaimed: 
 
M I was invited to take part in the screening on my 60th birthday I actually received the letter and I thought ‘this is the slippery slope’y 
 
Whereas this participant saw age as the ‘slippery slope’, others saw turning 60 as a social 
stigma or as having ‘one foot in the grave’. In a dialogue between a male and a female 
participant, the following was discussed: 
 
F It just seems a stigma, 60. 
M Everything’s aimed at 60 isn’t it? 
M Once you hit 60y 
F Makes it sound as if you’ve got one foot in the grave. 
M You’re on the slippery slope. 
F Yeah, slope down. 
 
 
Exposure to health screening 
The second factor to influence participation was prior exposure to, and past experience with, health 
screening. Our participants suggested that more frequent exposure to health screening is likely to 
result in an increase in body awareness and a greater acceptability of medical screening. This 
implies that prior events in an individual’s life (especially events that bring that person into contact 
with healthcare services) can be a powerful influence in shaping that individual’s response to health 
screening. Our participants further suggested that women were more likely to participate in the 
BCSP than men because many women (particularly women who have been through pregnancy and 
childbirth) have had more experience of health screening, and therefore, were less likely to be 
embarrassed when invited to complete the FOBt. In one exchange between male and female 
participants, we found that both men and women agreed that women are more likely to participate. 
 
F I think women will [participate] because women have had the breast checks, they have smear tests, they’ve had kids most of them and you know, 
there’s no dignity at all when you’ve had a child so I just think they’re more aware of their bodyy. Men are a bit more wary and personally I don’t 
think men would do it as much. 
F I think women [are more likely to participate in CRC screening] because I think we’re more bodily aware. 
M   WellyYes, it possibly is women,y. I think perhaps women do get checked over more often for other things and so this is one thing that they’d be quite 




The third factor to influence the screening decision was the presence or the absence of support 
and encouragement from significant others. Being in a significant relationship with a husband, 
wife or partner can be a positive driver for FOBt participation, especially for married men. This 
has been shown previously in a study by Thompson et al. (2011), who concluded that the best 
way to target men is through their wives. In contrast    to Thompson et al. (2011), our study 
indicates that targeting people in relationships can be beneficial for both men and women. As 
the FOBt is completed by individuals in the privacy of their own home, without a face-to-face 
consultation with a healthcare professional, it appears that having a husband, wife or partner may 
lower an individual’s anxiety about the test. Furthermore, being in a significant social relationship 
may increase the relative value and motivation to complete the FOBt.  One of our married male 
participants, who had completed the screening test, acknowledged the encouragement he had 
received from his wife when he said: 
 
M I think if I was on my own I’d have probably just binned it. 
 
Similarly, one of our female participants suggested that married men would be more likely to 
complete the test than single men. In her words: 
 
F I think men with partners are probably more likely to fill it in, because they’d probably get nagged by their wives. 
 
Two women, however, explained that it was the presence of a significant other that encouraged 




F I think it does work if you have either a wife or a partner, if there are two of you in the situation, I can understand one person on their own would 
probably just say ‘I can’t be bothered’. 
F I tend to think if you’re married that you would make sure you each did it. I’m not saying you’d be put off if you live on your own but I think if you’re 





Perception of risk 
Perception of risk was the fourth factor to influence participation, and our participants 
suggested that one of the reasons for not completing the FOBt was the belief that ‘it [cancer] 
won’t happen to me’. In doing so, they are referring to the ‘optimistic bias’, a term used to 
describe people underestimating the risk of something occurring and when they hold a belief 
that bad events happen only to other people (Lupton, 1999; Slovic, 2000). The participants in 
this study were found to underestimate the risk of developing CRC and admitted that they felt 
cancer would not affect them. As one gentleman explained: 
 
M   It’s what I cally the mobile phone syndrome it’s the ‘it won’t happen to me so why bother?’y people think ‘well I won’t have a car crash’ but then they’ve 
had a car crash. 
 
 
Although most of our participants believed that cancer affects only other people, their perceived 
risk of developing CRC, and hence the likelihood of them completing the FOBt, was shaped by 
key events in their unique biographical past. One participant, for example, described how her 
late husband was diagnosed with cancer despite having lived a healthy life, and after his death, 
her decisions about health screening continue to be shaped by this event. In her words: 
 
F   yyou think cancer is what somebody else gets, not what you get y then, I’ve got my husband who ran marathons, did cycling, didn’t smoke, occasionally 
dranky and then something like that happens [cancer diagnosis] and in so many months he passed away, and so straight away my attitude was ‘blow 
this healthy living y’. So, you know when people tell you [about cancer screening], again [I think that] it’s not going to happen to me’ but then you 
don’t know do you? If it’s going to happen it’s going to happen, but do I want to know any earlier? I know it could save my life, buty 
 
In contrast, some participants described how knowledge of another individual who had been 
diagnosed with cancer increased their willingness to participate in health screening by increasing 
their perceived vulnerability and reducing their optimistic bias. Importantly, a person’s subjective 
assessment of risk will often be influenced by their biographical past, suggesting that a key 
strategy for health promotion is to reduce the gap between actual and perceived risk. As one 
woman explained: 
 
F If somebody you know has suffered with whatever then it makes you think ‘should I be tested for this, should I do that?’ 
 
 
Fear of cancer 
‘Fear of cancer’ was the fifth factor to influence the decision to be screened. Our participants 
described cancer as the major health fear of their generation. They suggested that individuals 
may not complete the FOBt due to an underlying ‘fear of the result’. Although this fear was felt by 
both men and women, it was more readily expressed by men. Such behavioural responses to the 
FOBt are in opposition to the new public health ethos, where individuals are encouraged to be 
more active in seeking health information and more responsible in acting on that information 
(Lupton, 1999). Our participants suggested that some people prefer to remain ‘ignorant’ rather 
than seek knowledge that they could have cancer. In one dialogue, the participants explained: 
 
M I do feel today, in today’s society, the phrase ‘the big C’, as it’s euphemistically called, frightens lots of peopley 
F Yes. 
M And it tends to affect the whole of society, but I don’t think there’s anybody of my age now who hasn’t heard, or knows of somebody who has had contact 
with somebody who’s had cancer. Looking back to my mother and father’s time, the great killer was,y tuberculosis, and that died away and then 
cancer came along and it makes you wonder what nature’s going to throw at the human race next in the future. 
 
Some recognized ‘fear of cancer’ as a reason to be tested rather than a reason not to be tested, 
whereas others recognized the paradox between understanding the benefits but not wanting to 
know the result. In one exchange, the participants said: 
 
F It doesn’t make sense [non-participation in CRC screening] if everybody is so scared about it why don’t they do something about it? 
M Yeah, but ignorance is bliss, you know. M Especially amongst men. 
M That’s true though, yeah, it’s true. 
 
 
Lack of symptoms 
‘Lack of symptoms’ was the sixth factor to influence the decision to participate in the BCSP. 
This is especially problematic because many individuals will not display or notice symptoms 
in the early stage of the disease. This further compounds the effect of the optimistic bias 
because the importance of the FOBt is weakened when the perceived risk of developing 
cancer is low. This may be a particularly strong barrier for older people who are more familiar 
with the traditional model of consulting a doctor only when symptoms appear. One participant 
told us that people do not complete the testy 
 
F   Because if you’ve got no symptoms, you don’t feel unwelly then you don’t think about it. 
 
This was echoed by another participant who said: 
 
F So the issue you have really with doing any sort of test like that is you [have a symptom] which you then have to decide what to do withyYeah, so 




‘Embarrassment’ was the seventh factor to influence the decision to participate in the BCSP, and 
our participants suggested that the FOBt (and CRC more broadly) was something they were 
embarrassed to discuss with others, even in the privacy of their own home. This was seen as a 
challenge to be addressed in health promotion campaigns, and failure to address the sensitive 
nature  of  the screening test could result in both  a  low  participation rate and a low adherence 
rate. Individuals may agree with the concept of screening, and may understand that the benefits of 
screening outweigh the risks, but at the same time, they may find the practical realities  of 
completing the test to be a major obstacle. Thus, the programme may have a lower adherence rate 
than would be possible if the ‘embarrassment factor’ could be overcome. Among our participants, 
there was a general consensus that embarrassment, along with threats to dignity and privacy, are 
major barriers to their own personal decision to participate in, and adhere to, the programme. 
Indeed, our findings indicate that conversations about CRC among family and friends are often very 
limited, and thus, the decision to complete the FOBt becomes a very private  and personal decision. 
When asked what  prevented people from completing the screening test, one male participant 
simply replied ‘Embarrassment. That’s what it is’. 
This helps to explain the sex differential in both the participation rate and the adherence rate 
because in general, men are more reluctant to talk about embarrassing body parts than women. 
Encouraging people (men and women) to talk about bowel cancer is challenging because it is 
generally regarded as a socially unacceptable topic for conversation. Our participants captured 
this in the following dialogue: 
 
F Yeah, but if you were out with families or friends for an evening it’s not a subject that anybody would ever talk abouty You talk about the weather, 
you talk about holidays, you talk about families, you don’t talk about illnesses. 
M No, no. 




The final factor to influence the screening decision was ‘resistance to paternalism’. Some 
 
participants suggested that the implementation of the new preventative approach to healthcare, 
where people are encouraged to recognize early symptoms and take measures to prevent 
illness, tends to alienate or dehumanize their engagement with the health system. Some of our 
participants associated the messages of preventative healthcare with the ‘nanny state’, which 
they interpreted as being a threat to individual freedom and autonomy and as being overly broad 
and repetitive. This resistance to paternalism was more prevalent among the male participants; 
for example, one gentleman explained: 
 
M There is a contention which we all hear about in today’s society that the state, it’s a nanny state, OK? They tell us, don’t smoke, cut down on your drinking, 
don’t become obesey 
M   Take regular exercise, blah di blah di blahy andy then you’re exposed probably unwillingly or unknowingly to a cancer causing agent which 
changes the DNA within your bodyy and it runs amok, and all sorts of cancers can emanate from that one, I mean asbestos for instance, one fibre 
of asbestos, I should imagine anybody of my age has been exposed to severaly hundreds in fact. But the contention that it is becoming a nanny 
state, the amount of money that is actually being spent on media coverage of you should do this, you should do that, and all the rest of it, in some 
cases could be seen as counterproductive. All this, there’s too much nannying going on, you know, really. 
 
 
Discussion and conclusion 
This study explored the attitudes of people in the East Midlands of England towards the NHS 
BCSP and identified some of the factors that influence the uptake of the screening test. Much 
emphasis is placed on ‘public and patient choice’ within the ‘new’ NHS, and this is an important 
part of the context in which the current CRC screening is located (Rowe and Calnan, 2006). 
This may be seen as contradictory to the idea of ‘civic responsibility’, which was identified as 
an emerging theme in a study by Chapple et al. (2008). However, we suggest that ‘public and 
patient choice’ and ‘civic responsibility’ are 
compatible concepts as the public can choose to take on board the idea of ‘civic responsibility’ 
and, with this, complete the test for their own benefit and for the benefit of society. 
What is unique about this study is that we have shown how an individual’s biographical past 
can influence how they respond to the NHS BCSP and how they interpret the messages that 
encourage participation in the screening programme. In particular, our findings have shown 
that many individuals perceive the invitation to participate in the BCSP as being associated 
with entry into old age, and this conflicts with how they view themselves as individuals. While 
the rationale for targeting the BCSP at people aged 60–69 years is based on age-adjusted 
incidence rates for CRC, the test represented a ‘slippery slope’ for participants, whereby they 
had now entered into a social category that is more vulnerable to chronic illness. The findings 
also demonstrated how an individual’s previous experience with health screening can influence 
their attitude towards participation in the programme. Previous experiences of health screening, 
or intersections between one’s biographical past and cancer (either personal experience or 
knowledge of a social contact who had experienced a form of cancer), were seen as important 
factors that contribute towards shaping the higher value given to messages associated with the 
BCSP. Finally, our findings suggest that having stable and supportive relationships with 
significant others can be a positive driver for uptake. 
To conclude, we argue that to increase uptake in the NHS BCSP, more attention should be paid 
to increasing the level of trust between the individual and the  national health system. Although 
the ethos of the ‘new public health’ is founded on health prevention, health education and 
health promotion, the participants in this study viewed these messages as a form of medical 
paternalism, which lowered their weight and value when deciding whether or not to participate 
in the programme. We suggest further exploration into the interplay between an individual’s 
self-identity and their perceptions of risk in relation to developing bowel cancer. In so doing, 
future public health initiatives and interventions should be developed that will be more attentive 





The results of this study are limited to a small, self-selecting sample and a small geographical region 
in the East Midlands of England.  We acknowledge that a different sample in a different location may 
yield a different perspective on the programme. We also acknowledge that at times, the participants 
may have given the ‘socially acceptable’ answer rather than expose themselves to embarrassment in 
a social group. 
 
Despite these methodological limitations, we feel that our finding offer new insights that will be 
beneficial for policy makers, counsellors and GPs who give advice to patients considering whether or 
not to complete the CRC screening test. 
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